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Introduction: Mycosis Fungoides (MF) is a rare malignant T-cell lymphoma, involving mainly the skin. In 50%–75%
of cases, it can involve organs other than skin, with a 11%–14% Central Nervous System involvement (CNS).
Case report: A 82-year-old woman presented to our Department with a 15-years history of MF with skin lesions.
Neurological examination showed dysarthria and a left facio-brachial-crural hemiparesis. A CT scan showed a right
fronto-rolandic lesion. A MRI, including DWI, confirmed the presence of the “neoplastic” lesion with slight
hemorrhagic component and leptomeningeal contrast enhancement. Molecular TCR rearrangement test by PCR
analysis was performed on skin biopsy, showed the presence of a single peak which fits with a monoclonal TCRG
gene rearrangement (size 67). Molecular TCR test was also performed on the cerebrospinal fluid (CSF), which
confirmed the presence of lymphocyte clone T g/ more expressed with the same size of that observed in the skin
biopsy A total body CT scan did not show any lymphnodal or extranodal disease. The patient died after ten days.
Conclusion: MF usually occurs in the context of advanced and often histologically transformed cutaneous disease.
Isolated CNS involvement is remarkably rare. This case highlights the need for regular neurologic follow-up after the
diagnosis of MF, in particular when features that suggest risk of disease progression are present. Furthermore, the
analysis of the skin biopsy and above all of CSF by PCR technique, based on our experience, should always be
executed in MF patients with signs or symptoms suggesting CNS involvement.
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oma which mainly involves the skin. Generally, these are
indolent tumors, with a median survival rate of 8 to 9
years and they occur more commonly in men older than
50 years. Autopsy studies have demonstrated that the
disease may evolve into a generalized lymphoma involving
lymph nodes, lung, heart, spleen, and gastrointestinal tract
in approximately 50 to 75% of patients who have died of
MF and central nervous system (CNS) involvement in 11
to 14%. Nevertheless, an autopsy study reported central
nervous system (CNS) involvement in approximately 11 to
14% of patients died for MF. (Zonenshayn et al; 1998).* Correspondence: elisa.giorli@alice.it
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in any medium, provided the original work is pWe report a case of a 82 years old woman with a right
fronto-rolandic lesion due to MF localization, in which
the diagnosis was done mainly with PCR analysis of gene
rearrangements in the cerebrospinal fluid.
A 82-year-old woman was admitted to our Department
for generalized seizure and left-sided sensory-motor def-
icit. Personal history reported a 15-years lasting MF, with
isolated skin involvement. She reported paresthesia and
motor weakness of her left arm starting 10 days prior to
her hospitalization and arrived the Emergency Room after
a generalized tonic-clonic seizure. Physical examination
showed two large infiltrated and ulcerated skin lesions on
her right leg (Figure 1). Neurological examination showed
mild dysarthria and left sensory-motor deficit. Cerebral
CT scan showed a right fronto-rolandic hypodense lesion.
Brain MRI, including DWI, confirmed the presence of aopen access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Skin lesion on the right leg of patient.
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and leptomeningeal contrast enhancement (Figure 2). An
EEG showed polymorphic theta waves in the right temporal
region. The skin biopsy showed dermal infiltrate, primarily
containing lymphoid T-cells with cytological atypia and
immunophenotype CD3+, CD45+, focally CD 56-/+,
CD30-, ALK-, EBV-, myeloperoxidase-, TDT-, CD4-, CD8-.
Relying on previous studies (Lally et al. 2007), a molecular
TCR rearrangement test with PCR analysis was performed
on the skin biopsy, that showed the presence of a single
peak which fits with a monoclonal TCRG gene rearrange-
ment (size 67).
A molecular TCR test was also performed on the cere-
brospinal fluid (CSF) using different primer such describedFigure 2 MR imaging showing a proliferative lesion on right fronto-roin previous studies (Van Dongen et al; 2003), and con-
firmed the of expression of clone T g/ of the same size
of the ones observed in the skin biopsy (Figure 3). A
total-body CT scan did not show any other lymphnodal
or extranodal disease. The clinical course was very
severe and the patient died after ten days.
CNS involvement in MF usually occurs in the context of
advanced and often histologically transformed cutaneous
diseases. At presentation, the disease is usually limited to the
skin, with lesions that resemble eczema or psoriasis. Later
on it can spread to the deeper layers of the derm, with the
possibility of lymph nodes involvement; finally, visceral
involvement occurs, yet often subclinical (Bruggermann
et al; 2007). Lymph nodes are primarily involved in 75% of
cases, followed by lungs (66%), liver (53%) and spleen (60%),
although often multiple organs are affected (Weinstock and
Reynes 1999).
There are few studies dealing with risk assessment
and clinical course in patients with neurological symp-
toms due to MF. One study reported that nine patients
out of 680 consecutive newly diagnosed cases of MF
(1.3%) were found to have neurological involvement
during follow-up. All of them showed severe courses of
neurological disease (Weinstock and Reynes 1999).
CNS involvement is observed within an average of 3–
5 years from the initial diagnosis, typically occurring in
patients with advanced infiltration of other organs
(Stein et al. 2006), with autopsy demonstrating CNS
involvement in 11–14% of cases (Zonenshayn et al;
1998). During life, CNS involvement is unusual, having
been observed in 1.6% of 187 patients with cutaneouslandic region.
AB
Figure 3 T cell clonality testing by PCR analysis of TCR Gamma gene rearrangements. TCR clonality profiles were obtained by extracted
DNA from the diagnostic tissue for MF (A) and from cells (B) derived from CSF. The arrows indicate the TCRG monoclonal rearrangement.
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2001).
In 2 autopsy series consisting of 131 patients who died as
a result of MF, the most common form of CNS involve-
ment entailed the meninges (Kaufman et al. 1994), and only
nine patients (6.8%) had involvement of the brain paren-
chyma. In approximately half of the patients with CNS MF
a single area is affected, usually close to meninges; in the
other half of patients it is more likely to have a “cerebral
invasion” (Epstein et al. 1972).
The most common symptoms of CNS involvement in
MF are confusion, nausea, headaches, gait difficulties,
lethargy and weakness (Greene 1979), (Bodensteiner and
Skikne 1982). In conclusion, isolated CNS involvement in
MF without evidence of systemic disease is remarkably
rare and only few cases are described in literature.Moreover, this is the first case in which diagnosis of
certainty was made with the combined PCR analysis of
CSF and skin biopsy.
This case highlights the need for regular neurologic
follow-up after the diagnosis of MF, particularly in those
patients that are showing a progression of the disease.
We finally suggest to perform PCR analysis of skin
biopsy together with CSF in patients with CNS lesions
and Mycosis Fungoides.
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